Relevance of motoneuron specification and programmed cell death in embryos to therapy of ALS.
The molecular cues that generate spinal motoneurons in early embryonic development are well defined. Motoneurons are generated in excess and consequently undergo a natural period of programmed cell death. Although it is not known exactly how motoneurons compete for survival in embryonic development, it is hypothesized that they rely on the ability to access limited amounts of trophic factors from peripheral tissues, a process that is tightly regulated by skeletal muscle activity. Attempts to elucidate the molecular mechanisms that underlie motoneuron generation and programmed cell death in embryos have led to various effective strategies for treating injury and disease in animal models. Such studies provide great hope for the amelioration of human amyotrophic lateral sclerosis (ALS), a devastating progressive motoneuron degenerative disease. Here we review the clinical relevance of studying motoneuron specification and death during embryonic development.
Banks
Glen B
GB
Department of Neurology, University of Washington, Seattle, Washington 98195, USA. banksg@u.washington.edu
Chamberlain
Jeffrey S
JS
D000690:Amyotrophic Lateral Sclerosis / Q000628:therapy*; D000818:Animals; D030801:Animals, Genetically Modified; D017209:Apoptosis; D002454:Cell Differentiation; D004622:Embryo, Mammalian / Q000166:cytology* / Q000196:embryology; D047108:Embryonic Development; D015316:Genetic Therapy; D006801:Humans; D009046:Motor Neurons / Q000166:cytology* / Q000502:physiology